Person

Priya Singhal

Head of Development, Biogen

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$2.0M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 9, 2026BIIBSale2,660$199.83$532K
Feb 2, 2026BIIBSale748$179.30$134K
Sep 2, 2025BIIBSale517$133.55$69K
May 19, 2025BIIBSale3,806$126.25$481K
Dec 9, 2024BIIBSale110$157.21$17K
Sep 3, 2024BIIBSale431$204.22$88K
Apr 2, 2024BIIBSale93$213.09$20K
Feb 22, 2024BIIBSale262$221.23$58K
Feb 16, 2024BIIBSale108$221.49$24K
Feb 12, 2024BIIBSale419$239.45$100K
Feb 2, 2024BIIBSale634$245.93$156K
Dec 11, 2023BIIBSale110$248.00$27K
Sep 5, 2023BIIBSale431$269.43$116K
Jul 3, 2023BIIBSale81$282.87$23K
Apr 4, 2023BIIBSale91$277.11$25K
Mar 28, 2023BIIBSale568$270.06$153K

SEC reporting-owner ID (CIK) 1769608 · all filings on EDGAR